Market Cap 2.48B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 5,330,302
Avg Vol 8,705,696
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 81%
Beta 1.14
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Jul. 7 at 4:09 PM
$ABCL $ABCL They gave you the positive news this morning and then they gave you the dip buy opportunity....I hope you took advantage of it like I did
1 · Reply
PorkchopSquats
PorkchopSquats Jul. 7 at 2:53 PM
$ABCL Hourly chart looks like a M-top forming. Needs to stay above $7.25ish else we will be seeing more good dip buys. Still like the company long term, just short-term observation.
0 · Reply
Amires
Amires Jul. 7 at 2:50 PM
$ABCL We’re way past the point where retail can move the needle here. Volume has 4x’d over the last year and keeps trending up 📈. This is now a heavyweight fight: Institutional Longs vs. Shorts. ​I guarantee the $7-$8 zone is where a lot of long-term retail holders got shaken out by short manipulation last time around. But it’s different this time. The shorts are going to get squeezed hard because these institutions know the game and they do not panic sell. 💎🙌 ​Bears are trapped. Get ready for the squeeze! 🚀🔥🍋
1 · Reply
Arnoldsens
Arnoldsens Jul. 7 at 2:49 PM
$ABCL This stock never can hold pre-market gains. Buy in after hours sell in the morning.
1 · Reply
Targhee
Targhee Jul. 7 at 1:50 PM
$ABCL ding…ding…ding - the ring of opportunity!
1 · Reply
DeMampCamp
DeMampCamp Jul. 7 at 1:47 PM
$ABCL Well that was certainly annoying, hope you penny flippers are all happy with your measly gains, the longs here are in this for the long haul!
0 · Reply
Ckkung71
Ckkung71 Jul. 7 at 1:43 PM
$ABCL Insane attack again in opening 😅
0 · Reply
GSP
GSP Jul. 7 at 12:46 PM
My latest gapper watch list for Tuesday (con't): $ABCL $FIG $PPCB $CCHH $SKYQ .
0 · Reply
Dovkav
Dovkav Jul. 7 at 12:42 PM
0 · Reply
DeMampCamp
DeMampCamp Jul. 7 at 12:23 PM
$ABCL Nice upgrade this morning, exciting times!
0 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 6 hours ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 1 day ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 4 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 4 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 8 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 10 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Stocktradesmoon
Stocktradesmoon Jul. 7 at 4:09 PM
$ABCL $ABCL They gave you the positive news this morning and then they gave you the dip buy opportunity....I hope you took advantage of it like I did
1 · Reply
PorkchopSquats
PorkchopSquats Jul. 7 at 2:53 PM
$ABCL Hourly chart looks like a M-top forming. Needs to stay above $7.25ish else we will be seeing more good dip buys. Still like the company long term, just short-term observation.
0 · Reply
Amires
Amires Jul. 7 at 2:50 PM
$ABCL We’re way past the point where retail can move the needle here. Volume has 4x’d over the last year and keeps trending up 📈. This is now a heavyweight fight: Institutional Longs vs. Shorts. ​I guarantee the $7-$8 zone is where a lot of long-term retail holders got shaken out by short manipulation last time around. But it’s different this time. The shorts are going to get squeezed hard because these institutions know the game and they do not panic sell. 💎🙌 ​Bears are trapped. Get ready for the squeeze! 🚀🔥🍋
1 · Reply
Arnoldsens
Arnoldsens Jul. 7 at 2:49 PM
$ABCL This stock never can hold pre-market gains. Buy in after hours sell in the morning.
1 · Reply
Targhee
Targhee Jul. 7 at 1:50 PM
$ABCL ding…ding…ding - the ring of opportunity!
1 · Reply
DeMampCamp
DeMampCamp Jul. 7 at 1:47 PM
$ABCL Well that was certainly annoying, hope you penny flippers are all happy with your measly gains, the longs here are in this for the long haul!
0 · Reply
Ckkung71
Ckkung71 Jul. 7 at 1:43 PM
$ABCL Insane attack again in opening 😅
0 · Reply
GSP
GSP Jul. 7 at 12:46 PM
My latest gapper watch list for Tuesday (con't): $ABCL $FIG $PPCB $CCHH $SKYQ .
0 · Reply
Dovkav
Dovkav Jul. 7 at 12:42 PM
0 · Reply
DeMampCamp
DeMampCamp Jul. 7 at 12:23 PM
$ABCL Nice upgrade this morning, exciting times!
0 · Reply
GSP
GSP Jul. 7 at 12:09 PM
$ABCL 235m float: AbCellera Appoints Dr. Lynn Seely to its Board of Directors
0 · Reply
GSP
GSP Jul. 7 at 12:06 PM
Updated gapper watch list (con't): $ABCL $FIG .
0 · Reply
notreload_ai
notreload_ai Jul. 7 at 11:57 AM
New $JAZZ partnership triggers Benchmark upgrade for $ABCL to Buy with $11 price target. $56M upfront + milestone potential in oncology. https://notreload.xyz/xy/benchmark-upgrades-abcellera-to-buy-on-major-jazz-partnership/
0 · Reply
Targhee
Targhee Jul. 7 at 11:28 AM
$ABCL https://www.tipranks.com/news/the-fly/abcellera-upgraded-to-buy-from-hold-at-benchmark-thefly-news
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 7 at 9:15 AM
$ABCL Abcellera is one of the most bullish charts in the stock market $ABCL $XBI
0 · Reply
ShelleyWarrick
ShelleyWarrick Jul. 7 at 3:59 AM
$VMHG Victory Marine Holdings' Subsidiary Dunn & Groux Beverage Holdings Activates Distribution Across Six U.S. Markets https://finance.yahoo.com/small-business/articles/victory-marine-holdings-subsidiary-dunn-201500164.html $ROOT $NCLH $ABCL
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 7 at 3:25 AM
$ABCL A stacked board doesn’t change NK3R biology. Phase 2 still has to hit its endpoint. This is a setup signal, not a data signal. But $JAZZ deal + Sandor + Seely in 3 weeks? Cleanest pre-catalyst setup I’ve seen from $ABCL . Long. NFA.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 7 at 3:24 AM
$ABCL The board sequence tells the story: Nov ’25 → Quake (platform science) Jun 5 → Sandor (Phase 3 execution) Jul 6 → Seely (FDA approval + commercialization) Science ✅ Clinical ✅ Commercial ✅ $ABCL is building the board for a positive readout. Q3 2026 is the test.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 7 at 3:23 AM
$ABCL • Medivation CMO → approved Xtandi → $14B Pfizer buyout • Myovant CEO → approved Myfembree + Orgovyx • Blueprint board → $9.1B Sanofi acquisition • Trained endocrinologist (UCSD) You don’t hire this profile pre-Phase 2 unless you’re planning for after. $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 7 at 3:23 AM
$ABCL $ABCL just added Dr. Lynn Seely to its board. She’s the ex-CEO of Myovant who took Myfembree (women’s hormonal health) from zero → FDA approval. ABCL635 = NK3R antibody for menopause VMS. Same patient pop. Same FDA division. 8 weeks before Phase 2 data. Not random. 🧵
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 6 at 11:41 PM
$ABCL $ABCL is a gamechanger in human longevity through their research in cancer treatments. They are developing world's first non-toxic cancer treatments via antibody/TCE compared to chemotherapy. One of the upsides noted in ABCL635 is the oncology side-benefits. Multibagger stock.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 6 at 11:23 PM
$ABCL $ABCL Time passes by… Before long, the market's evaluation and value will change.🚀
0 · Reply